朱曦

學歷：博士

專家類別：講師,，碩導

郵箱：[email protected]

通訊地址：云南省昆明市呈貢區(qū)雨花街道春融西路1168號

郵編：650500

簡歷

教育經(jīng)歷

(1) 2015-09至2021-06，上海交通大學，生物醫(yī)學工程,，博士

(2) 2011-09至2015-06,，中南大學,，生物醫(yī)學工程,，學士

工作經(jīng)歷

(1) 2023-05至 今，昆明醫(yī)科大學,，生物醫(yī)學工程研究院,，講師

(2) 2021-12至2023-04，昆明醫(yī)科大學,，康復學院,，講師

研究方向

腫瘤光學檢測和治療

招生方向

招生專業(yè)：病理與病理生理學（100104）

歡迎對生物醫(yī)學工程和生物醫(yī)學光子學感興趣的同學報考10學科代碼

承擔科研項目

（1）國家自然科學基金，地區(qū)項目,，82460369,，用于細胞外囊泡循環(huán)動力學活體監(jiān)測的熒光相關(guān)活體流式技術(shù)研究，2025-01至2028-12,，32萬元,，在研，主持

（2）云南省科技廳,，面上項目,，202301AT070272，不完全光動力治療引起的炎癥反應(yīng)加速殘余腫瘤發(fā)展的機制研究,，2023-06至2026-05,，10萬元，在研,，主持

（3）云南省科技廳-昆醫(yī)聯(lián)合專項,，面上項目,，靶向活化血小板的納米膠束用于深層轉(zhuǎn)移灶的聲動力治療和光聲成像,，2023-06 至 2026-05,，10萬元，在研,，主持

（4）云南省教育廳,， 2023Y0619，酒精注射用于抑制射頻消融術(shù)中腫瘤播散的療效研究,，2023-03至 2025-02,，2萬元，在研,，主持

研究成果（論文,、專利、專著等）

[1]Zhu X*, Suo Y*, Fu Y, et al. In vivo flow cytometry reveals a circadian rhythm of circulating tumor cell.Light: Science & Applications, 2021, 10(1):1-10. 

[2] Zhu X*, Wei C*, Zhang Y, et al. Monitoring radiofrequency therapy‐induced tumor cell dissemination by in vivo flow cytometry[J].Cytometry Part A, 2021, 99(6):593-600.

[3] Zhuang B*, Zhu X*, Zhang F, et al. Radiofrequency ablation promote in vivo hepatocellular carcinoma cell releasing into the blood.European Radiology Experimental, 2023, 7:74.

[4] Yu Q*, Yao, Y,* Zhu X*, et al. In Vivo Flow Cytometric Evaluation of Circulating Metastatic Pancreatic Tumor Cells after High-intensity Focused Ultrasound Therapy.Cytometry Part A, 2020, 97(9): 900-908.

[5] Xia J, Ma S, Zhu X, et al. Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches[J]. Science Advances, 2022, 8(6): eabj1262.

[6] Tao L, Liu Q, Zhang F, Fu Y, Zhu X, et al. Microglia modulation with 1070-nm light attenuates Aβ burden and cognitive impairment in Alzheimer’s disease mouse model[J]. Light: Science & Applications, 2021, 10(1): 1-14.

[7] Zhang Y, Zhu X, Chen X, et al. Activated Platelets‐Targeting Micelles with Controlled Drug Release for Effective Treatment of Primary and Metastatic Triple Negative Breast Cancer[J].Advanced Functional Materials, 2019, 29(13): 1806620.

[8] Weng X, Wei D, Zhu X, et al. Real‐time monitoring of single circulating tumor cells with a fluorescently labeled deoxy‐glucose by in vivo flow cytometry[J]. Cytometry Part A, 2021, 99(6): 586- 592. 

[9] Suo Y, Xie C, Zhu X, et al. Proportion of circulating tumor cell clusters increases during cancer metastasis[J]. Cytometry Part A, 2017, 91(3): 250-253.

[10] Pang K, Xie C, Yang Z, Suo Y, Zhu X, et al. Monitoring circulating prostate cancer cells by in vivo flow cytometry assesses androgen deprivation therapy on metastasis[J]. Cytometry Part A, 2018, 93(5): 517-524.